M.D. Anderson Cancer Center: Leukemia trials

The registry lists 302 Leukemia studies with M.D. Anderson Cancer Center as lead sponsor. 5 are open to participants now and 169 have results posted.

Early Phase 1 1Phase 1 121Phase 2 201Phase 3 13No phase 26(a study in two phases counts in both)

Studies

Page 4 of 4. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaCompletedNCT00002832Phase 1/2
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute LeukemiaCompletedNCT00002831Phase 1/2

All Leukemia studies →M.D. Anderson Cancer Center: all focus areas →